APA (7th ed.) Citation

Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh, & Su-jin Rhee. (2022). Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh, and Su-jin Rhee. Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Yewon Park, et al. Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment. Frontiers Media S.A., 2022.